Paris, France

Claudie Gautier

This inventor holds 1 USPTO granted patent. Top assignee: Elf Sanofi. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claudie Gautier. Retrieved from https://idiyas.com/inventor/claudie-gautier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Claudie Gautier: Innovator in Thiazole Derivatives

Introduction

Claudie Gautier is a notable inventor based in Paris, France. He has made significant contributions to the field of chemistry, particularly in the development of branched alkylamino derivatives of thiazole. His innovative work has led to the creation of a patent that showcases his expertise and creativity.

Latest Patents

Claudie Gautier holds a patent for "Branched alkylamino derivatives of thiazole, processes for preparing." This invention relates to derivatives of a specific formula, where various radicals are represented, including phenyl, naphthyl, and alkyl groups. The patent highlights the complexity and potential applications of these chemical compounds.

Career Highlights

Gautier is associated with Elf Sanofi, a prominent company in the pharmaceutical industry. His work at Elf Sanofi has allowed him to explore and develop innovative solutions in the field of chemistry. With a total of 1 patent, he has established himself as a valuable contributor to scientific advancements.

Collaborations

Throughout his career, Claudie Gautier has collaborated with esteemed colleagues, including Gilles Courtemanche and Camille G. Wermuth. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Claudie Gautier's contributions to the field of chemistry, particularly through his patent on thiazole derivatives, demonstrate his commitment to innovation. His work continues to influence the industry and showcases the importance of collaboration in scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…